Trials / Unknown
UnknownNCT04154358
Implementing HPV DNA Self-Collection to Increase Rates of Cervical Cancer Screening in Transgender Men
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Augusta University · Academic / Other
- Sex
- Female
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
Transgender men are individuals born genetically female that have a gender identity that is incongruent with their biological sex. For those who have begun or completed transition, they may present as males but still have a uterus and cervix. Thus far, no distinction has been made between routine cervical cancer screening guidelines in non-transgender women and those for transgender men, despite wide variations in sexual practices, including lifelong vaginal abstinence. The purpose of this study is to offer transgender men seen at clinic visits self-collected HPV testing to evaluate for improved cervical cancer screening rates, as well as a survey to further investigate sexual practices, rates of appropriate screening prior to being offered self-collection, and barriers to obtaining appropriate care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | HPV testing | will perform HPV testing with self-collected specimen |
Timeline
- Start date
- 2020-05-01
- Primary completion
- 2020-06-30
- Completion
- 2020-12-31
- First posted
- 2019-11-06
- Last updated
- 2020-03-23
Source: ClinicalTrials.gov record NCT04154358. Inclusion in this directory is not an endorsement.